Apoteka ApS — Credit Rating and Financial Key Figures
CVR number: 36905549
Kildebrøndevej 44 A, 2670 Greve
mgl@apoteka.dk
tel: 30320935
www.apoteka.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -9 563.36 | 1 922.25 | -5 295.83 | -33 371.91 | -16 593.62 |
Employee benefit expenses | -11 531.87 | -15 652.10 | -24 392.44 | -28 863.61 | -30 737.08 |
Total depreciation | -1 587.61 | -1 768.27 | -2 361.12 | -2 996.90 | -3 070.61 |
EBIT | -22 682.85 | -15 498.12 | -32 049.39 | -65 232.43 | -50 401.31 |
Other financial income | 0.69 | 5.14 | 2.40 | 0.98 | 491.89 |
Other financial expenses | - 325.94 | - 165.72 | - 267.80 | -4 151.29 | -3 822.81 |
Pre-tax profit | -23 008.10 | -15 658.70 | -32 314.79 | -69 382.74 | -53 732.22 |
Income taxes | 2 704.04 | 3 084.40 | -1 390.44 | -30.36 | 77.41 |
Net earnings | -20 304.07 | -12 574.29 | -33 705.23 | -69 413.10 | -53 654.82 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 8 298.93 | 10 918.90 | 15 890.40 | 19 204.82 | 22 046.88 |
Intangible assets total | 8 298.93 | 10 918.90 | 15 890.40 | 19 204.82 | 22 046.88 |
Buildings | 125.48 | 67.52 | 50.79 | 20.67 | 5 878.01 |
Machinery and equipment | 165.48 | 111.86 | 58.92 | 29.37 | 463.44 |
Tangible assets total | 290.96 | 179.39 | 109.71 | 50.05 | 6 341.46 |
Holdings in group member companies | 50.00 | 2 870.44 | 2 870.44 | 2 870.44 | 2 870.44 |
Investments total | 50.00 | 2 870.44 | 2 870.44 | 2 870.44 | 6 719.87 |
Non-curr. owed by group member comp. | 3 435.96 | 16 130.82 | 27 451.11 | ||
Long term receivables total | 3 435.96 | 16 130.82 | 27 451.11 | ||
Inventories total | |||||
Current trade debtors | 354.58 | 4 382.98 | 3 026.31 | 5 960.01 | 1 645.58 |
Current amounts owed by group member comp. | 4 341.98 | ||||
Prepayments and accrued income | 79.98 | 899.65 | 39.05 | 1 165.41 | 828.86 |
Current other receivables | 6.00 | 29.59 | 970.08 | 254.55 | 1 622.41 |
Current deferred tax assets | 7 139.07 | 9 353.89 | 7 057.06 | 4 729.82 | 4 807.23 |
Short term receivables total | 7 579.63 | 14 666.11 | 11 092.50 | 12 109.80 | 13 246.06 |
Cash and bank deposits | 782.04 | 8 517.91 | 2 967.41 | 8 477.25 | 4 115.66 |
Cash and cash equivalents | 782.04 | 8 517.91 | 2 967.41 | 8 477.25 | 4 115.66 |
Balance sheet total (assets) | 20 437.53 | 37 152.74 | 32 930.47 | 58 843.18 | 79 921.03 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 146.63 | 175.64 | 185.96 | 185.96 | 185.96 |
Other reserves | 6 473.17 | 8 516.74 | 12 394.51 | 14 979.76 | 17 196.56 |
Retained earnings | 17 427.22 | 32 400.00 | 29 437.62 | 85 147.15 | 13 517.25 |
Profit of the financial year | -20 304.07 | -12 574.29 | -33 705.23 | -69 413.10 | -53 654.82 |
Shareholders equity total | 3 742.95 | 28 518.09 | 8 312.86 | 30 899.77 | -22 755.05 |
Provisions | 500.00 | ||||
Non-current accruals and deferred income | 4 180.09 | ||||
Non-current other liabilities | 334.37 | 966.39 | 12 729.81 | ||
Non-current deferred tax liabilities | 20 022.27 | 14 784.25 | |||
Non-current liabilities total | 334.37 | 966.39 | 12 729.81 | 20 022.27 | 18 964.34 |
Current loans from credit institutions | 4 280.58 | ||||
Advances received | 2 209.40 | ||||
Current trade creditors | 5 281.63 | 3 624.66 | 5 199.59 | 6 910.12 | 13 406.51 |
Current owed to participating | 7 300.17 | ||||
Current owed to group member | 5 129.47 | 137.50 | 63 325.70 | ||
Other non-interest bearing current liabilities | 1 569.01 | 4 043.59 | 1 558.75 | 873.52 | 2 198.95 |
Current liabilities total | 16 360.21 | 7 668.25 | 11 887.80 | 7 921.14 | 83 211.74 |
Balance sheet total (liabilities) | 20 437.53 | 37 152.74 | 32 930.47 | 58 843.18 | 79 921.03 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.